AW:FW:COVID19 Test Solution PCR/Antigen/Antibody (Attn: Bolsaonline Publi Purchase)

lunes, 21 de septiembre de 2020

Dear Bolsaonline Publi,,bfkeo

How are you? Hope my email finds you very well!2020/9/21

As per latest company policy, I would update you the latest aggreesive scheme on RT-PCT Solution of Lepu Medical, from today on "10000 Test Reagents get qPCR System Free", which will help you get a much cost effective solution to meet the needs of COVID19 screening and control.

FYI, we also have quality SARS-CoV-2 Antibody Test which will offer more support on the Combat-COVID19 works,
1. SARS-CoV-2 Antigen Rapid Test Kit (improved board type and mobile app support), CE approval, advanced card design for easier operation.
2. SARS-CoV-2 Antibody Test (a rapid diagnosis device get result within 15 mins), CE approvel, exported 40 million pcs worldwide, exporting white listed, ensuring global level best price.
As well as,
3. Infrared Forehead Thermometers (with amazing offer at 9 dollars a pc), BSI and CE approval, top class quality, Germany Sensor, exporting white listed
4. Fingertip Pulse Oximeters, CE approval, top class quality, plenty production capacity of supply, at 8 dollars a pc only.
Looking forward for your valuable comments.

Thanks and Regards,

武杨帅 Eric Wu
Mobile/Wechat/Whatsapp: +86-189 1038 6989
Skype: capteric99
Lepu Medical Technology Beijing Co Ltd    (StockCode 300003:CH Shenzhen)
Add: Building 3, No.37 Chaoqian Rd., Changping District, Beijing- China, 102200
Part of Subsidiaries
Lepu Intellegence:
The content of this email is confidential and intended for the recipient specified in message only. It is strictly forbidden to share any part of this message with any third party, without a written consent of the sender. If you received this message by mistake, please reply to this message and follow with its deletion, so that we can ensure such a mistake does not occur in the future.
in case this email was sent by mistake to your id, please inform us to remove your id from our list, sorry for any inconvenience cuased

0 comentarios: